IMM 4.41% 35.5¢ immutep limited

Ann: Prima Raises $20 million in Share Purchase P, page-15

  1. 2,306 Posts.
    re: Ann: Prima Raises $20 million in Share Pu... from the Company announcement just sent via email
    ASX/Media Release (Code: PRR)
    28 June 2011
    Prima BioMed raises $20 million in Share Purchase Plan

    the closing paragraphs are critical ....

    " Prima?s lead product is CVacTM ovarian cancer therapy treatment. It has completed two successful clinical trials and is progressing toward eventual commercialization in the United States, Australia, Europe, and globally. "

    ... and the juicy bit .....

    " The Company?s broader, long term goal is to develop commercial cancer treatment technologies and programs for global markets. "

    ... seems like there may not only be a few more rabbits in the hat .... but a few bloody big elephants to come out of that same hat

    ... but ' technologies ' and treatments to compliment and / or supplement cVac .... oh the potential

    .... now if that isn't exciting for the ' long term hold'... and years and years of income stream ... I don't know what is .

    ... sub 30c will be long gone in a fews weeks ... onwards and upwards

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.015(4.41%)
Mkt cap ! $515.6M
Open High Low Value Volume
34.0¢ 36.0¢ 34.0¢ $1.270M 3.611M

Buyers (Bids)

No. Vol. Price($)
7 286261 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 253490 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.